Bardin Hill Management Partners’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-27,226
Closed -$2.64M 44
2019
Q3
$2.64M Sell
27,226
-143,092
-84% -$14.3M 0.46% 25
2019
Q2
$17.4M Buy
170,318
+66,697
+64% +$7.2M 2.41% 16
2019
Q1
$11.8M Buy
+103,621
New +$7.62M 1.85% 16

Bardin Hill Management Partners's ONCE Position: Q4 2019 in Review

Bardin Hill Management Partners sold out of Spark Therapeutics, Inc. Common Stock (ONCE) in Q4 2019, closing a stake of 27,226 shares — an estimated $2.64M sold.

Bardin Hill Management Partners first reported a position in ONCE in Q1 2019 and held it in 3 quarters. The position peaked at $17.4M in Q2 2019. 0 funds tracked by Wall St. Rank hold ONCE as of Q4 2019.

  • Bardin Hill Management Partners reported no remaining Spark Therapeutics, Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
  • Bardin Hill Management Partners sold 27,226 Spark Therapeutics, Inc. Common Stock shares in Q4 2019, an estimated $2.64M.
  • Bardin Hill Management Partners first reported a position in Spark Therapeutics, Inc. Common Stock in Q1 2019 and held it in 3 quarters.
  • Bardin Hill Management Partners's Spark Therapeutics, Inc. Common Stock position peaked at $17.4M in Q2 2019.
  • 0 funds tracked by Wall St. Rank held Spark Therapeutics, Inc. Common Stock as of Q4 2019.

Based on Bardin Hill Management Partners's 13F filing for Q4 2019, filed 14 Feb 2020.